nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—POR—Doxorubicin—pancreatic cancer	0.342	0.483	CbGbCtD
Nilutamide—CYP2C8—Tamoxifen—pancreatic cancer	0.0789	0.111	CbGbCtD
Nilutamide—CYP2C8—Erlotinib—pancreatic cancer	0.0671	0.0947	CbGbCtD
Nilutamide—CYP2C19—Tamoxifen—pancreatic cancer	0.0662	0.0934	CbGbCtD
Nilutamide—CYP2C8—Fluorouracil—pancreatic cancer	0.0582	0.0821	CbGbCtD
Nilutamide—CYP2C9—Tamoxifen—pancreatic cancer	0.055	0.0777	CbGbCtD
Nilutamide—CYP2C9—Fluorouracil—pancreatic cancer	0.0406	0.0573	CbGbCtD
Nilutamide—Flutamide—AHR—pancreatic cancer	0.00873	1	CrCbGaD
Nilutamide—AR—FOXA1 transcription factor network—TFF1—pancreatic cancer	0.000504	0.0539	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptors—NR5A2—pancreatic cancer	0.000475	0.0508	CbGpPWpGaD
Nilutamide—Rhinitis—Docetaxel—pancreatic cancer	0.00045	0.00164	CcSEcCtD
Nilutamide—Oedema—Gemcitabine—pancreatic cancer	0.000449	0.00164	CcSEcCtD
Nilutamide—Cardiac failure—Epirubicin—pancreatic cancer	0.000448	0.00164	CcSEcCtD
Nilutamide—Diarrhoea—Tamoxifen—pancreatic cancer	0.000447	0.00163	CcSEcCtD
Nilutamide—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000446	0.00163	CcSEcCtD
Nilutamide—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000446	0.00163	CcSEcCtD
Nilutamide—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000443	0.00162	CcSEcCtD
Nilutamide—Body temperature increased—Sunitinib—pancreatic cancer	0.000442	0.00162	CcSEcCtD
Nilutamide—Abdominal pain—Sunitinib—pancreatic cancer	0.000442	0.00162	CcSEcCtD
Nilutamide—Diarrhoea—Erlotinib—pancreatic cancer	0.000442	0.00162	CcSEcCtD
Nilutamide—Oedema peripheral—Docetaxel—pancreatic cancer	0.000442	0.00162	CcSEcCtD
Nilutamide—Oedema—Fluorouracil—pancreatic cancer	0.000441	0.00161	CcSEcCtD
Nilutamide—Urethral disorder—Docetaxel—pancreatic cancer	0.00044	0.00161	CcSEcCtD
Nilutamide—Anorexia—Irinotecan—pancreatic cancer	0.000439	0.00161	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000437	0.0016	CcSEcCtD
Nilutamide—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000434	0.00159	CcSEcCtD
Nilutamide—Hot flush—Doxorubicin—pancreatic cancer	0.000432	0.00158	CcSEcCtD
Nilutamide—Visual impairment—Docetaxel—pancreatic cancer	0.000432	0.00158	CcSEcCtD
Nilutamide—Dizziness—Tamoxifen—pancreatic cancer	0.000432	0.00158	CcSEcCtD
Nilutamide—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.000429	0.00157	CcSEcCtD
Nilutamide—Anorexia—Gemcitabine—pancreatic cancer	0.000428	0.00157	CcSEcCtD
Nilutamide—Dizziness—Erlotinib—pancreatic cancer	0.000427	0.00156	CcSEcCtD
Nilutamide—Anorexia—Fluorouracil—pancreatic cancer	0.000421	0.00154	CcSEcCtD
Nilutamide—Insomnia—Irinotecan—pancreatic cancer	0.000417	0.00152	CcSEcCtD
Nilutamide—Vomiting—Tamoxifen—pancreatic cancer	0.000415	0.00152	CcSEcCtD
Nilutamide—Cardiac failure—Doxorubicin—pancreatic cancer	0.000415	0.00152	CcSEcCtD
Nilutamide—Paraesthesia—Irinotecan—pancreatic cancer	0.000414	0.00151	CcSEcCtD
Nilutamide—Rash—Tamoxifen—pancreatic cancer	0.000412	0.00151	CcSEcCtD
Nilutamide—Dermatitis—Tamoxifen—pancreatic cancer	0.000412	0.0015	CcSEcCtD
Nilutamide—Vomiting—Erlotinib—pancreatic cancer	0.000411	0.0015	CcSEcCtD
Nilutamide—Dyspnoea—Irinotecan—pancreatic cancer	0.000411	0.0015	CcSEcCtD
Nilutamide—Blood creatinine increased—Epirubicin—pancreatic cancer	0.00041	0.0015	CcSEcCtD
Nilutamide—Headache—Tamoxifen—pancreatic cancer	0.000409	0.0015	CcSEcCtD
Nilutamide—Rash—Erlotinib—pancreatic cancer	0.000408	0.00149	CcSEcCtD
Nilutamide—Dermatitis—Erlotinib—pancreatic cancer	0.000407	0.00149	CcSEcCtD
Nilutamide—Insomnia—Gemcitabine—pancreatic cancer	0.000406	0.00148	CcSEcCtD
Nilutamide—Dyspepsia—Irinotecan—pancreatic cancer	0.000406	0.00148	CcSEcCtD
Nilutamide—Headache—Erlotinib—pancreatic cancer	0.000405	0.00148	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000405	0.00148	CcSEcCtD
Nilutamide—Paraesthesia—Gemcitabine—pancreatic cancer	0.000403	0.00147	CcSEcCtD
Nilutamide—Asthenia—Sunitinib—pancreatic cancer	0.000401	0.00147	CcSEcCtD
Nilutamide—Dry skin—Epirubicin—pancreatic cancer	0.000401	0.00147	CcSEcCtD
Nilutamide—Decreased appetite—Irinotecan—pancreatic cancer	0.000401	0.00147	CcSEcCtD
Nilutamide—Dyspnoea—Gemcitabine—pancreatic cancer	0.0004	0.00146	CcSEcCtD
Nilutamide—Insomnia—Fluorouracil—pancreatic cancer	0.000399	0.00146	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000398	0.00146	CcSEcCtD
Nilutamide—Paraesthesia—Fluorouracil—pancreatic cancer	0.000396	0.00145	CcSEcCtD
Nilutamide—Alopecia—Docetaxel—pancreatic cancer	0.000396	0.00145	CcSEcCtD
Nilutamide—Pruritus—Sunitinib—pancreatic cancer	0.000396	0.00145	CcSEcCtD
Nilutamide—Pain—Irinotecan—pancreatic cancer	0.000394	0.00144	CcSEcCtD
Nilutamide—Constipation—Irinotecan—pancreatic cancer	0.000394	0.00144	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000394	0.00144	CcSEcCtD
Nilutamide—Dyspnoea—Fluorouracil—pancreatic cancer	0.000394	0.00144	CcSEcCtD
Nilutamide—Decreased appetite—Gemcitabine—pancreatic cancer	0.00039	0.00143	CcSEcCtD
Nilutamide—Dyspepsia—Fluorouracil—pancreatic cancer	0.000389	0.00142	CcSEcCtD
Nilutamide—Nausea—Tamoxifen—pancreatic cancer	0.000388	0.00142	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000388	0.00142	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000386	0.00141	CcSEcCtD
Nilutamide—Constipation—Gemcitabine—pancreatic cancer	0.000384	0.0014	CcSEcCtD
Nilutamide—Pain—Gemcitabine—pancreatic cancer	0.000384	0.0014	CcSEcCtD
Nilutamide—Nausea—Erlotinib—pancreatic cancer	0.000384	0.0014	CcSEcCtD
Nilutamide—Decreased appetite—Fluorouracil—pancreatic cancer	0.000384	0.0014	CcSEcCtD
Nilutamide—Diarrhoea—Sunitinib—pancreatic cancer	0.000383	0.0014	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000381	0.00139	CcSEcCtD
Nilutamide—AR—Notch-mediated HES/HEY network—RBBP8—pancreatic cancer	0.00038	0.0406	CbGpPWpGaD
Nilutamide—Feeling abnormal—Irinotecan—pancreatic cancer	0.00038	0.00139	CcSEcCtD
Nilutamide—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000379	0.00139	CcSEcCtD
Nilutamide—Influenza—Epirubicin—pancreatic cancer	0.000378	0.00138	CcSEcCtD
Nilutamide—Back pain—Docetaxel—pancreatic cancer	0.000378	0.00138	CcSEcCtD
Nilutamide—Pain—Fluorouracil—pancreatic cancer	0.000377	0.00138	CcSEcCtD
Nilutamide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000377	0.00138	CcSEcCtD
Nilutamide—AR—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.000376	0.0401	CbGpPWpGaD
Nilutamide—Dry skin—Doxorubicin—pancreatic cancer	0.000371	0.00136	CcSEcCtD
Nilutamide—Dizziness—Sunitinib—pancreatic cancer	0.00037	0.00135	CcSEcCtD
Nilutamide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00037	0.00135	CcSEcCtD
Nilutamide—Angina pectoris—Epirubicin—pancreatic cancer	0.000368	0.00135	CcSEcCtD
Nilutamide—Abdominal pain—Irinotecan—pancreatic cancer	0.000364	0.00133	CcSEcCtD
Nilutamide—Body temperature increased—Irinotecan—pancreatic cancer	0.000364	0.00133	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000364	0.00133	CcSEcCtD
Nilutamide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000364	0.00133	CcSEcCtD
Nilutamide—Anaemia—Docetaxel—pancreatic cancer	0.000361	0.00132	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000357	0.0013	CcSEcCtD
Nilutamide—Vomiting—Sunitinib—pancreatic cancer	0.000356	0.0013	CcSEcCtD
Nilutamide—Body temperature increased—Gemcitabine—pancreatic cancer	0.000355	0.0013	CcSEcCtD
Nilutamide—Rash—Sunitinib—pancreatic cancer	0.000353	0.00129	CcSEcCtD
Nilutamide—Dermatitis—Sunitinib—pancreatic cancer	0.000352	0.00129	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000351	0.00128	CcSEcCtD
Nilutamide—Headache—Sunitinib—pancreatic cancer	0.000351	0.00128	CcSEcCtD
Nilutamide—Syncope—Docetaxel—pancreatic cancer	0.00035	0.00128	CcSEcCtD
Nilutamide—Influenza—Doxorubicin—pancreatic cancer	0.00035	0.00128	CcSEcCtD
Nilutamide—Leukopenia—Docetaxel—pancreatic cancer	0.000349	0.00128	CcSEcCtD
Nilutamide—Body temperature increased—Fluorouracil—pancreatic cancer	0.000349	0.00128	CcSEcCtD
Nilutamide—AR—Integrated Breast Cancer Pathway—BACH1—pancreatic cancer	0.000343	0.0367	CbGpPWpGaD
Nilutamide—Loss of consciousness—Docetaxel—pancreatic cancer	0.000343	0.00125	CcSEcCtD
Nilutamide—Weight decreased—Epirubicin—pancreatic cancer	0.000342	0.00125	CcSEcCtD
Nilutamide—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000341	0.00125	CcSEcCtD
Nilutamide—Cough—Docetaxel—pancreatic cancer	0.000341	0.00125	CcSEcCtD
Nilutamide—Angina pectoris—Doxorubicin—pancreatic cancer	0.000341	0.00125	CcSEcCtD
Nilutamide—Pneumonia—Epirubicin—pancreatic cancer	0.000339	0.00124	CcSEcCtD
Nilutamide—Hypertension—Docetaxel—pancreatic cancer	0.000337	0.00123	CcSEcCtD
Nilutamide—Chest pain—Docetaxel—pancreatic cancer	0.000332	0.00122	CcSEcCtD
Nilutamide—Nausea—Sunitinib—pancreatic cancer	0.000332	0.00122	CcSEcCtD
Nilutamide—Asthenia—Irinotecan—pancreatic cancer	0.000331	0.00121	CcSEcCtD
Nilutamide—Urinary tract infection—Epirubicin—pancreatic cancer	0.000328	0.0012	CcSEcCtD
Nilutamide—Dry mouth—Docetaxel—pancreatic cancer	0.000325	0.00119	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000325	0.00119	CcSEcCtD
Nilutamide—Sweating—Epirubicin—pancreatic cancer	0.000323	0.00118	CcSEcCtD
Nilutamide—Asthenia—Gemcitabine—pancreatic cancer	0.000322	0.00118	CcSEcCtD
Nilutamide—Haematuria—Epirubicin—pancreatic cancer	0.000321	0.00117	CcSEcCtD
Nilutamide—Oedema—Docetaxel—pancreatic cancer	0.000319	0.00117	CcSEcCtD
Nilutamide—Pruritus—Gemcitabine—pancreatic cancer	0.000318	0.00116	CcSEcCtD
Nilutamide—Weight decreased—Doxorubicin—pancreatic cancer	0.000316	0.00116	CcSEcCtD
Nilutamide—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000315	0.00115	CcSEcCtD
Nilutamide—Diarrhoea—Irinotecan—pancreatic cancer	0.000315	0.00115	CcSEcCtD
Nilutamide—Pneumonia—Doxorubicin—pancreatic cancer	0.000314	0.00115	CcSEcCtD
Nilutamide—Shock—Docetaxel—pancreatic cancer	0.000313	0.00115	CcSEcCtD
Nilutamide—Pruritus—Fluorouracil—pancreatic cancer	0.000312	0.00114	CcSEcCtD
Nilutamide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000307	0.00112	CcSEcCtD
Nilutamide—Dizziness—Irinotecan—pancreatic cancer	0.000305	0.00111	CcSEcCtD
Nilutamide—Anorexia—Docetaxel—pancreatic cancer	0.000304	0.00111	CcSEcCtD
Nilutamide—Rhinitis—Epirubicin—pancreatic cancer	0.000303	0.00111	CcSEcCtD
Nilutamide—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000303	0.00111	CcSEcCtD
Nilutamide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000302	0.0011	CcSEcCtD
Nilutamide—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000301	0.0011	CcSEcCtD
Nilutamide—Sweating—Doxorubicin—pancreatic cancer	0.000299	0.00109	CcSEcCtD
Nilutamide—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000299	0.00109	CcSEcCtD
Nilutamide—Oedema peripheral—Epirubicin—pancreatic cancer	0.000298	0.00109	CcSEcCtD
Nilutamide—Haematuria—Doxorubicin—pancreatic cancer	0.000297	0.00109	CcSEcCtD
Nilutamide—Urethral disorder—Epirubicin—pancreatic cancer	0.000297	0.00108	CcSEcCtD
Nilutamide—Vomiting—Irinotecan—pancreatic cancer	0.000293	0.00107	CcSEcCtD
Nilutamide—Dizziness—Fluorouracil—pancreatic cancer	0.000292	0.00107	CcSEcCtD
Nilutamide—Visual impairment—Epirubicin—pancreatic cancer	0.000291	0.00107	CcSEcCtD
Nilutamide—Rash—Irinotecan—pancreatic cancer	0.000291	0.00106	CcSEcCtD
Nilutamide—Dermatitis—Irinotecan—pancreatic cancer	0.00029	0.00106	CcSEcCtD
Nilutamide—Headache—Irinotecan—pancreatic cancer	0.000289	0.00106	CcSEcCtD
Nilutamide—Insomnia—Docetaxel—pancreatic cancer	0.000288	0.00105	CcSEcCtD
Nilutamide—Paraesthesia—Docetaxel—pancreatic cancer	0.000286	0.00105	CcSEcCtD
Nilutamide—Vomiting—Gemcitabine—pancreatic cancer	0.000285	0.00104	CcSEcCtD
Nilutamide—AR—Notch-mediated HES/HEY network—HEY2—pancreatic cancer	0.000285	0.0304	CbGpPWpGaD
Nilutamide—Dyspnoea—Docetaxel—pancreatic cancer	0.000284	0.00104	CcSEcCtD
Nilutamide—Rash—Gemcitabine—pancreatic cancer	0.000283	0.00104	CcSEcCtD
Nilutamide—Dermatitis—Gemcitabine—pancreatic cancer	0.000283	0.00103	CcSEcCtD
Nilutamide—Headache—Gemcitabine—pancreatic cancer	0.000281	0.00103	CcSEcCtD
Nilutamide—Vomiting—Fluorouracil—pancreatic cancer	0.000281	0.00103	CcSEcCtD
Nilutamide—Rhinitis—Doxorubicin—pancreatic cancer	0.000281	0.00103	CcSEcCtD
Nilutamide—Dyspepsia—Docetaxel—pancreatic cancer	0.00028	0.00103	CcSEcCtD
Nilutamide—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000278	0.00102	CcSEcCtD
Nilutamide—Rash—Fluorouracil—pancreatic cancer	0.000278	0.00102	CcSEcCtD
Nilutamide—Dermatitis—Fluorouracil—pancreatic cancer	0.000278	0.00102	CcSEcCtD
Nilutamide—Decreased appetite—Docetaxel—pancreatic cancer	0.000277	0.00101	CcSEcCtD
Nilutamide—Headache—Fluorouracil—pancreatic cancer	0.000277	0.00101	CcSEcCtD
Nilutamide—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000276	0.00101	CcSEcCtD
Nilutamide—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000276	0.00101	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000275	0.00101	CcSEcCtD
Nilutamide—Urethral disorder—Doxorubicin—pancreatic cancer	0.000274	0.001	CcSEcCtD
Nilutamide—Nausea—Irinotecan—pancreatic cancer	0.000274	0.001	CcSEcCtD
Nilutamide—Constipation—Docetaxel—pancreatic cancer	0.000272	0.000996	CcSEcCtD
Nilutamide—Pain—Docetaxel—pancreatic cancer	0.000272	0.000996	CcSEcCtD
Nilutamide—Visual impairment—Doxorubicin—pancreatic cancer	0.00027	0.000986	CcSEcCtD
Nilutamide—Alopecia—Epirubicin—pancreatic cancer	0.000267	0.000977	CcSEcCtD
Nilutamide—Nausea—Gemcitabine—pancreatic cancer	0.000267	0.000975	CcSEcCtD
Nilutamide—AR—Notch-mediated HES/HEY network—HEY1—pancreatic cancer	0.000263	0.0281	CbGpPWpGaD
Nilutamide—Feeling abnormal—Docetaxel—pancreatic cancer	0.000263	0.00096	CcSEcCtD
Nilutamide—Nausea—Fluorouracil—pancreatic cancer	0.000262	0.000959	CcSEcCtD
Nilutamide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000261	0.000953	CcSEcCtD
Nilutamide—AR—Integrated Breast Cancer Pathway—GDI1—pancreatic cancer	0.00026	0.0278	CbGpPWpGaD
Nilutamide—Tension—Epirubicin—pancreatic cancer	0.000258	0.000945	CcSEcCtD
Nilutamide—Nervousness—Epirubicin—pancreatic cancer	0.000256	0.000935	CcSEcCtD
Nilutamide—Back pain—Epirubicin—pancreatic cancer	0.000255	0.000931	CcSEcCtD
Nilutamide—Body temperature increased—Docetaxel—pancreatic cancer	0.000252	0.000921	CcSEcCtD
Nilutamide—Abdominal pain—Docetaxel—pancreatic cancer	0.000252	0.000921	CcSEcCtD
Nilutamide—Alopecia—Doxorubicin—pancreatic cancer	0.000247	0.000904	CcSEcCtD
Nilutamide—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000244	0.000893	CcSEcCtD
Nilutamide—Anaemia—Epirubicin—pancreatic cancer	0.000243	0.00089	CcSEcCtD
Nilutamide—Tension—Doxorubicin—pancreatic cancer	0.000239	0.000874	CcSEcCtD
Nilutamide—Malaise—Epirubicin—pancreatic cancer	0.000237	0.000868	CcSEcCtD
Nilutamide—Nervousness—Doxorubicin—pancreatic cancer	0.000237	0.000865	CcSEcCtD
Nilutamide—Syncope—Epirubicin—pancreatic cancer	0.000236	0.000864	CcSEcCtD
Nilutamide—Leukopenia—Epirubicin—pancreatic cancer	0.000236	0.000862	CcSEcCtD
Nilutamide—Back pain—Doxorubicin—pancreatic cancer	0.000236	0.000862	CcSEcCtD
Nilutamide—AR—FOXA1 transcription factor network—SHH—pancreatic cancer	0.000232	0.0247	CbGpPWpGaD
Nilutamide—Loss of consciousness—Epirubicin—pancreatic cancer	0.000231	0.000846	CcSEcCtD
Nilutamide—Cough—Epirubicin—pancreatic cancer	0.00023	0.00084	CcSEcCtD
Nilutamide—Asthenia—Docetaxel—pancreatic cancer	0.000229	0.000836	CcSEcCtD
Nilutamide—Hypertension—Epirubicin—pancreatic cancer	0.000227	0.000831	CcSEcCtD
Nilutamide—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000226	0.000827	CcSEcCtD
Nilutamide—Pruritus—Docetaxel—pancreatic cancer	0.000225	0.000824	CcSEcCtD
Nilutamide—Anaemia—Doxorubicin—pancreatic cancer	0.000225	0.000824	CcSEcCtD
Nilutamide—Chest pain—Epirubicin—pancreatic cancer	0.000224	0.00082	CcSEcCtD
Nilutamide—Discomfort—Epirubicin—pancreatic cancer	0.000221	0.00081	CcSEcCtD
Nilutamide—Malaise—Doxorubicin—pancreatic cancer	0.00022	0.000803	CcSEcCtD
Nilutamide—Dry mouth—Epirubicin—pancreatic cancer	0.000219	0.000802	CcSEcCtD
Nilutamide—Syncope—Doxorubicin—pancreatic cancer	0.000218	0.000799	CcSEcCtD
Nilutamide—Leukopenia—Doxorubicin—pancreatic cancer	0.000218	0.000798	CcSEcCtD
Nilutamide—Diarrhoea—Docetaxel—pancreatic cancer	0.000218	0.000797	CcSEcCtD
Nilutamide—Oedema—Epirubicin—pancreatic cancer	0.000215	0.000786	CcSEcCtD
Nilutamide—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000214	0.000783	CcSEcCtD
Nilutamide—Cough—Doxorubicin—pancreatic cancer	0.000213	0.000777	CcSEcCtD
Nilutamide—Shock—Epirubicin—pancreatic cancer	0.000211	0.000773	CcSEcCtD
Nilutamide—Dizziness—Docetaxel—pancreatic cancer	0.000211	0.00077	CcSEcCtD
Nilutamide—Hypertension—Doxorubicin—pancreatic cancer	0.00021	0.000769	CcSEcCtD
Nilutamide—AR—Androgen receptor signaling pathway—DAXX—pancreatic cancer	0.000209	0.0223	CbGpPWpGaD
Nilutamide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000208	0.00076	CcSEcCtD
Nilutamide—Chest pain—Doxorubicin—pancreatic cancer	0.000207	0.000759	CcSEcCtD
Nilutamide—Discomfort—Doxorubicin—pancreatic cancer	0.000205	0.000749	CcSEcCtD
Nilutamide—Anorexia—Epirubicin—pancreatic cancer	0.000205	0.000749	CcSEcCtD
Nilutamide—Dry mouth—Doxorubicin—pancreatic cancer	0.000203	0.000742	CcSEcCtD
Nilutamide—Vomiting—Docetaxel—pancreatic cancer	0.000203	0.000741	CcSEcCtD
Nilutamide—Rash—Docetaxel—pancreatic cancer	0.000201	0.000735	CcSEcCtD
Nilutamide—Dermatitis—Docetaxel—pancreatic cancer	0.000201	0.000734	CcSEcCtD
Nilutamide—Headache—Docetaxel—pancreatic cancer	0.0002	0.00073	CcSEcCtD
Nilutamide—Oedema—Doxorubicin—pancreatic cancer	0.000199	0.000727	CcSEcCtD
Nilutamide—Shock—Doxorubicin—pancreatic cancer	0.000196	0.000715	CcSEcCtD
Nilutamide—Insomnia—Epirubicin—pancreatic cancer	0.000194	0.000711	CcSEcCtD
Nilutamide—Paraesthesia—Epirubicin—pancreatic cancer	0.000193	0.000706	CcSEcCtD
Nilutamide—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000192	0.000703	CcSEcCtD
Nilutamide—Dyspnoea—Epirubicin—pancreatic cancer	0.000192	0.000701	CcSEcCtD
Nilutamide—Anorexia—Doxorubicin—pancreatic cancer	0.00019	0.000693	CcSEcCtD
Nilutamide—Nausea—Docetaxel—pancreatic cancer	0.000189	0.000692	CcSEcCtD
Nilutamide—Dyspepsia—Epirubicin—pancreatic cancer	0.000189	0.000692	CcSEcCtD
Nilutamide—Decreased appetite—Epirubicin—pancreatic cancer	0.000187	0.000683	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000186	0.000678	CcSEcCtD
Nilutamide—Constipation—Epirubicin—pancreatic cancer	0.000184	0.000672	CcSEcCtD
Nilutamide—Pain—Epirubicin—pancreatic cancer	0.000184	0.000672	CcSEcCtD
Nilutamide—Insomnia—Doxorubicin—pancreatic cancer	0.00018	0.000658	CcSEcCtD
Nilutamide—AR—FOXA1 transcription factor network—GCG—pancreatic cancer	0.000179	0.0191	CbGpPWpGaD
Nilutamide—Paraesthesia—Doxorubicin—pancreatic cancer	0.000179	0.000653	CcSEcCtD
Nilutamide—Dyspnoea—Doxorubicin—pancreatic cancer	0.000177	0.000648	CcSEcCtD
Nilutamide—Feeling abnormal—Epirubicin—pancreatic cancer	0.000177	0.000648	CcSEcCtD
Nilutamide—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000176	0.000643	CcSEcCtD
Nilutamide—Dyspepsia—Doxorubicin—pancreatic cancer	0.000175	0.00064	CcSEcCtD
Nilutamide—Decreased appetite—Doxorubicin—pancreatic cancer	0.000173	0.000632	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000172	0.000628	CcSEcCtD
Nilutamide—Constipation—Doxorubicin—pancreatic cancer	0.00017	0.000622	CcSEcCtD
Nilutamide—Pain—Doxorubicin—pancreatic cancer	0.00017	0.000622	CcSEcCtD
Nilutamide—Abdominal pain—Epirubicin—pancreatic cancer	0.00017	0.000621	CcSEcCtD
Nilutamide—Body temperature increased—Epirubicin—pancreatic cancer	0.00017	0.000621	CcSEcCtD
Nilutamide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000164	0.000599	CcSEcCtD
Nilutamide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000163	0.000595	CcSEcCtD
Nilutamide—Abdominal pain—Doxorubicin—pancreatic cancer	0.000157	0.000575	CcSEcCtD
Nilutamide—Body temperature increased—Doxorubicin—pancreatic cancer	0.000157	0.000575	CcSEcCtD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000156	0.0166	CbGpPWpGaD
Nilutamide—Asthenia—Epirubicin—pancreatic cancer	0.000154	0.000564	CcSEcCtD
Nilutamide—Pruritus—Epirubicin—pancreatic cancer	0.000152	0.000556	CcSEcCtD
Nilutamide—Diarrhoea—Epirubicin—pancreatic cancer	0.000147	0.000538	CcSEcCtD
Nilutamide—Asthenia—Doxorubicin—pancreatic cancer	0.000143	0.000522	CcSEcCtD
Nilutamide—Dizziness—Epirubicin—pancreatic cancer	0.000142	0.00052	CcSEcCtD
Nilutamide—Pruritus—Doxorubicin—pancreatic cancer	0.000141	0.000514	CcSEcCtD
Nilutamide—Vomiting—Epirubicin—pancreatic cancer	0.000137	0.0005	CcSEcCtD
Nilutamide—AR—Notch-mediated HES/HEY network—HES1—pancreatic cancer	0.000137	0.0146	CbGpPWpGaD
Nilutamide—Diarrhoea—Doxorubicin—pancreatic cancer	0.000136	0.000498	CcSEcCtD
Nilutamide—Rash—Epirubicin—pancreatic cancer	0.000135	0.000496	CcSEcCtD
Nilutamide—Dermatitis—Epirubicin—pancreatic cancer	0.000135	0.000495	CcSEcCtD
Nilutamide—Headache—Epirubicin—pancreatic cancer	0.000135	0.000492	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.000133	0.0142	CbGpPWpGaD
Nilutamide—Dizziness—Doxorubicin—pancreatic cancer	0.000131	0.000481	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.000128	0.0137	CbGpPWpGaD
Nilutamide—Nausea—Epirubicin—pancreatic cancer	0.000128	0.000467	CcSEcCtD
Nilutamide—Vomiting—Doxorubicin—pancreatic cancer	0.000126	0.000462	CcSEcCtD
Nilutamide—Rash—Doxorubicin—pancreatic cancer	0.000125	0.000458	CcSEcCtD
Nilutamide—Dermatitis—Doxorubicin—pancreatic cancer	0.000125	0.000458	CcSEcCtD
Nilutamide—Headache—Doxorubicin—pancreatic cancer	0.000125	0.000456	CcSEcCtD
Nilutamide—Nausea—Doxorubicin—pancreatic cancer	0.000118	0.000432	CcSEcCtD
Nilutamide—AR—Nuclear Receptors—PPARG—pancreatic cancer	0.000115	0.0123	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—HIF1A—pancreatic cancer	0.000114	0.0122	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000113	0.0121	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—KDR—pancreatic cancer	0.000109	0.0117	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—NOTCH1—pancreatic cancer	0.000103	0.011	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.000101	0.0108	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—AHR—pancreatic cancer	9.88e-05	0.0106	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—RB1—pancreatic cancer	9.31e-05	0.00994	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	9.11e-05	0.00973	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	9.05e-05	0.00966	CbGpPWpGaD
Nilutamide—AR—Nongenotropic Androgen signaling—SRC—pancreatic cancer	8.63e-05	0.00922	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—SMAD4—pancreatic cancer	8.39e-05	0.00896	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	7.98e-05	0.00852	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—pancreatic cancer	7.82e-05	0.00835	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—GADD45A—pancreatic cancer	7.33e-05	0.00783	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—SST—pancreatic cancer	7.3e-05	0.00779	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	7.16e-05	0.00764	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	7.07e-05	0.00755	CbGpPWpGaD
Nilutamide—CYP2C19—Melatonin metabolism and effects—APOE—pancreatic cancer	6.86e-05	0.00733	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—CDKN2A—pancreatic cancer	6.64e-05	0.00709	CbGpPWpGaD
Nilutamide—AR—Nongenotropic Androgen signaling—PIK3CA—pancreatic cancer	6.57e-05	0.00701	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NR5A2—pancreatic cancer	6.49e-05	0.00693	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—STK11—pancreatic cancer	6.27e-05	0.0067	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	6.18e-05	0.0066	CbGpPWpGaD
Nilutamide—AR—Nongenotropic Androgen signaling—HRAS—pancreatic cancer	6.08e-05	0.00649	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	6.07e-05	0.00648	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—pancreatic cancer	6.06e-05	0.00647	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—STAT3—pancreatic cancer	5.97e-05	0.00637	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—pancreatic cancer	5.84e-05	0.00623	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—BRCA2—pancreatic cancer	5.67e-05	0.00606	CbGpPWpGaD
Nilutamide—AR—Regulation of Androgen receptor activity—SRC—pancreatic cancer	5.62e-05	0.006	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—CCND1—pancreatic cancer	5.61e-05	0.00599	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—RB1—pancreatic cancer	5.59e-05	0.00597	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—CTNNB1—pancreatic cancer	5.56e-05	0.00594	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—SMAD4—pancreatic cancer	5.5e-05	0.00587	CbGpPWpGaD
Nilutamide—AR—Nongenotropic Androgen signaling—AKT1—pancreatic cancer	5.37e-05	0.00573	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—pancreatic cancer	5.35e-05	0.00571	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—HES1—pancreatic cancer	5.23e-05	0.00558	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	5.2e-05	0.00555	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—pancreatic cancer	4.85e-05	0.00518	CbGpPWpGaD
Nilutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	4.8e-05	0.00512	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	4.7e-05	0.00502	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	4.55e-05	0.00486	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—pancreatic cancer	4.52e-05	0.00482	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	4.49e-05	0.00479	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—pancreatic cancer	4.47e-05	0.00478	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	4.47e-05	0.00478	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—pancreatic cancer	4.39e-05	0.00468	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	4.38e-05	0.00468	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—CCND1—pancreatic cancer	4.15e-05	0.00443	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—CTNNB1—pancreatic cancer	4.11e-05	0.00439	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—PTEN—pancreatic cancer	4e-05	0.00428	CbGpPWpGaD
Nilutamide—AR—Gene Expression—CHD3—pancreatic cancer	3.73e-05	0.00398	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—MEN1—pancreatic cancer	3.73e-05	0.00398	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—SRC—pancreatic cancer	3.71e-05	0.00397	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	3.66e-05	0.00391	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	3.65e-05	0.00389	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—pancreatic cancer	3.62e-05	0.00387	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	3.59e-05	0.00383	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—STAT3—pancreatic cancer	3.58e-05	0.00382	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NOTCH4—pancreatic cancer	3.53e-05	0.00377	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—pancreatic cancer	3.41e-05	0.00364	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	3.39e-05	0.00362	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—EGFR—pancreatic cancer	3.25e-05	0.00348	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.24e-05	0.00347	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NR5A2—pancreatic cancer	3.12e-05	0.00334	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—AKT1—pancreatic cancer	3.12e-05	0.00333	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—pancreatic cancer	3.04e-05	0.00325	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NOTCH3—pancreatic cancer	3e-05	0.00321	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	2.84e-05	0.00304	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	2.79e-05	0.00298	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	2.77e-05	0.00296	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	2.72e-05	0.00291	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	2.72e-05	0.0029	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	2.69e-05	0.00287	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	2.62e-05	0.0028	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	2.62e-05	0.0028	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.49e-05	0.00266	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	2.49e-05	0.00266	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	2.37e-05	0.00253	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.31e-05	0.00247	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	2.31e-05	0.00247	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—AKT1—pancreatic cancer	2.31e-05	0.00246	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—SMAD4—pancreatic cancer	2.26e-05	0.00242	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.25e-05	0.00241	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.23e-05	0.00238	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	2.18e-05	0.00233	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.17e-05	0.00232	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	2.13e-05	0.00228	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.02e-05	0.00215	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	2.01e-05	0.00215	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—TNF—pancreatic cancer	1.98e-05	0.00211	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.96e-05	0.0021	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.81e-05	0.00193	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.8e-05	0.00192	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MEN1—pancreatic cancer	1.79e-05	0.00192	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	1.79e-05	0.00191	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.77e-05	0.00189	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NOTCH4—pancreatic cancer	1.7e-05	0.00182	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.68e-05	0.0018	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.67e-05	0.00178	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	1.67e-05	0.00178	CbGpPWpGaD
Nilutamide—AR—Gene Expression—HSPA1B—pancreatic cancer	1.62e-05	0.00173	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—PPARG—pancreatic cancer	1.57e-05	0.00168	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.53e-05	0.00164	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	1.51e-05	0.00161	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.48e-05	0.00158	CbGpPWpGaD
Nilutamide—AR—Gene Expression—EZH2—pancreatic cancer	1.48e-05	0.00158	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NOTCH3—pancreatic cancer	1.45e-05	0.00154	CbGpPWpGaD
Nilutamide—AR—Gene Expression—HSPA1A—pancreatic cancer	1.37e-05	0.00146	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.25e-05	0.00134	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PRSS1—pancreatic cancer	1.14e-05	0.00121	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SMAD4—pancreatic cancer	1.09e-05	0.00116	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PRSS1—pancreatic cancer	1.01e-05	0.00108	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ARG2—pancreatic cancer	9.85e-06	0.00105	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PRSS1—pancreatic cancer	9.25e-06	0.000988	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—MYC—pancreatic cancer	8.97e-06	0.000958	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ARG2—pancreatic cancer	8.79e-06	0.000939	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—TYMP—pancreatic cancer	8.61e-06	0.00092	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NOTCH1—pancreatic cancer	8.03e-06	0.000857	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ARG2—pancreatic cancer	8.02e-06	0.000856	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—TYMP—pancreatic cancer	7.69e-06	0.000821	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PPARG—pancreatic cancer	7.58e-06	0.000809	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.11e-06	0.000759	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—TYMP—pancreatic cancer	7.01e-06	0.000748	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GLP1R—pancreatic cancer	6.94e-06	0.000741	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—DPYD—pancreatic cancer	6.83e-06	0.000729	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	6.48e-06	0.000692	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.41e-06	0.000685	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.34e-06	0.000677	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GLP1R—pancreatic cancer	6.2e-06	0.000662	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.19e-06	0.000661	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—DPYD—pancreatic cancer	6.1e-06	0.000651	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	5.78e-06	0.000618	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.78e-06	0.000618	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.72e-06	0.000611	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GLP1R—pancreatic cancer	5.65e-06	0.000603	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.64e-06	0.000602	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—DPYD—pancreatic cancer	5.56e-06	0.000594	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.52e-06	0.00059	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	5.27e-06	0.000563	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.22e-06	0.000557	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.04e-06	0.000538	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.03e-06	0.000537	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CD44—pancreatic cancer	5.02e-06	0.000536	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.91e-06	0.000525	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.87e-06	0.00052	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GCG—pancreatic cancer	4.81e-06	0.000514	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.59e-06	0.00049	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—STK11—pancreatic cancer	4.52e-06	0.000483	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CD44—pancreatic cancer	4.48e-06	0.000478	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.39e-06	0.000468	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.35e-06	0.000464	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MYC—pancreatic cancer	4.32e-06	0.000461	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GCG—pancreatic cancer	4.29e-06	0.000459	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.25e-06	0.000453	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CD44—pancreatic cancer	4.08e-06	0.000436	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—STK11—pancreatic cancer	4.04e-06	0.000431	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4e-06	0.000427	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.96e-06	0.000423	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GCG—pancreatic cancer	3.92e-06	0.000418	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—TYMS—pancreatic cancer	3.89e-06	0.000416	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.79e-06	0.000405	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—STK11—pancreatic cancer	3.68e-06	0.000393	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—TYMS—pancreatic cancer	3.47e-06	0.000371	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.46e-06	0.000369	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—TYMS—pancreatic cancer	3.17e-06	0.000338	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOE—pancreatic cancer	3.16e-06	0.000338	CbGpPWpGaD
Nilutamide—AR—Gene Expression—AKT1—pancreatic cancer	3e-06	0.00032	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3e-06	0.00032	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	2.86e-06	0.000305	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOE—pancreatic cancer	2.82e-06	0.000302	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARG—pancreatic cancer	2.76e-06	0.000294	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.67e-06	0.000286	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOE—pancreatic cancer	2.58e-06	0.000275	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	2.55e-06	0.000272	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	2.51e-06	0.000268	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARG—pancreatic cancer	2.46e-06	0.000263	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.44e-06	0.00026	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2.32e-06	0.000248	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.24e-06	0.00024	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.24e-06	0.000239	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	2.19e-06	0.000234	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS2—pancreatic cancer	2.17e-06	0.000232	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.04e-06	0.000218	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.95e-06	0.000209	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.94e-06	0.000207	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTEN—pancreatic cancer	1.89e-06	0.000202	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.78e-06	0.00019	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.76e-06	0.000188	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.69e-06	0.00018	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.54e-06	0.000164	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.33e-06	0.000142	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.19e-06	0.000127	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.09e-06	0.000116	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.09e-06	0.000116	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AKT1—pancreatic cancer	9.73e-07	0.000104	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKT1—pancreatic cancer	8.87e-07	9.47e-05	CbGpPWpGaD
